Brevan Howard Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$491K Buy
5,881
+1,124
+24% +$92.2K ﹤0.01% 1310
2025
Q4
$436K Sell
4,757
-11,557
-71% -$1.11M ﹤0.01% 1178
2025
Q3
$1.55M Sell
16,314
-11,141
-41% -$1.05M 0.01% 685
2025
Q2
$2.88M Buy
27,455
+19,050
+227% +$1.81M 0.02% 593
2025
Q1
$743K Buy
8,405
+6,316
+302% +$648K 0.01% 600
2024
Q4
$200K Buy
+2,089
New +$195K ﹤0.01% 914

Other funds holding HQY

Brevan Howard Capital Management's HQY Position: Q1 2026 in Review

Brevan Howard Capital Management increased its HealthEquity (HQY) stake by 24% in Q1 2026, buying an estimated $92.2K and bringing the position to 5,881 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Brevan Howard Capital Management first reported a position in HQY in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.88M in Q2 2025. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Brevan Howard Capital Management held 5,881 shares of HealthEquity worth $491K as of Q1 2026.
  • Brevan Howard Capital Management bought 1,124 HealthEquity shares in Q1 2026, an estimated $92.2K.
  • HealthEquity made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1310 holding.
  • Brevan Howard Capital Management first reported a position in HealthEquity in Q4 2024 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's HealthEquity position peaked at $2.88M in Q2 2025.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.